We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Top Buys

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$23.5M
2
BMO icon
Bank of Montreal
BMO
+$13.2M
3
MPWR icon
Monolithic Power Systems
MPWR
+$10.1M
4
SILJ icon
Amplify Junior Silver Miners ETF
SILJ
+$9.5M
5
COPX icon
Global X Copper Miners ETF NEW
COPX
+$8.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.8M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$4.39M
3
MSFT icon
Microsoft
MSFT
+$3.76M
4
SGML icon
Sigma Lithium
SGML
+$3.53M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RBRK icon
376
Rubrik
RBRK
$21.6B
$76K 0.02%
1,000
-10,000
-91% -$767K
PII icon
377
Polaris
PII
$3.91B
$75K 0.02%
+1,200
New +$79K
RIVN icon
378
Rivian
RIVN
$22.9B
$75K 0.02%
+3,815
New +$60.6K
RSKD icon
379
Riskified
RSKD
$863M
$75K 0.02%
15,110
– –
FLG
380
Flagstar Bank National Association
FLG
$5.92B
$75K 0.02%
6,000
+3,816
+175% +$45.6K
SOPH icon
381
SOPHiA GENETICS
SOPH
$649M
$74K 0.02%
16,010
-28,695
-64% -$130K
TMC icon
382
TMC The Metals Company
TMC
$1.91B
$74K 0.02%
12,000
-9,666
-45% -$67.9K
GAP
383
The Gap Inc
GAP
$7.34B
$74K 0.02%
2,894
-5,842
-67% -$142K
CP icon
384
Canadian Pacific Kansas City
CP
$82.6B
$73K 0.02%
+1,000
New +$73.6K
PENN icon
385
PENN Entertainment
PENN
$2.53B
$73K 0.02%
5,000
+255
+5% +$3.98K
RYAAY icon
386
Ryanair
RYAAY
$30.7B
$72K 0.02%
+1,000
New +$65K
FICO icon
387
Fair Isaac
FICO
$24B
$71K 0.02%
42
-136
-76% -$234K
RAL
388
Ralliant Corp
RAL
$7.9B
$71K 0.02%
1,396
-2,100
-60% -$98.4K
GLIBA
389
Liberty Capital Corp Series A GCI Group Common Stock
GLIBA
$1.07B
$71K 0.02%
1,933
– –
ITUB icon
390
Itaú Unibanco
ITUB
$80.9B
$70K 0.02%
+9,846
New +$70K
SYK icon
391
Stryker
SYK
$131B
$70K 0.02%
200
+50
+33% +$18.2K
ARCC icon
392
Ares Capital
ARCC
$14.5B
$68K 0.02%
+3,400
New +$68.6K
BRZE icon
393
Braze
BRZE
$3.36B
$68K 0.02%
2,000
-48
-2% -$1.42K
EQR icon
394
Equity Residential
EQR
$24.7B
$68K 0.02%
1,080
+1,010
+1,443% +$62K
FGNX
395
FG Nexus Inc
FGNX
$43.5M
$68K 0.02%
5,000
-5,920
-54% -$104K
QCOM icon
396
Qualcomm
QCOM
$173B
$68K 0.02%
400
-600
-60% -$103K
LBTYB
397
DELISTED
Liberty Global plc Class B
LBTYB
$68K 0.02%
5,875
– –
ENHA
398
Enhanced Group Inc
ENHA
$322M
$67K 0.02%
+6,725
New +$67.3K
ELME
399
Elme Communities
ELME
$144M
$66K 0.02%
+3,830
New +$64.9K
ILMN icon
400
Illumina
ILMN
$29.1B
$65K 0.02%
500
-501
-50% -$58.8K
14 15
16
17 18

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.